# Taurine - Clinical Longevity Review & Consensus Audit

> **Consensus Verdict**: Taurine is a conditionally essential semi-sulfonated beta-amino acid that declines by over 80% during mammalian aging. Supplementation (1.5–3g daily) rescues mitochondrial tRNA 5-taurinomethyluridine modification, restores respiratory Complex I assembly, stimulates endothelial eNOS for significant blood pressure reduction (-7.2 mmHg SBP), and extended median lifespan by 10-12% in landmark 2023 Science studies.

## 1. Executive Summary & Scores
- **Longevity Evidence Score**: **92/100**
- **Evidence Quality Tier**: **silver**
- **Human Clinical Evidence Strength**: 93/100
- **Primary Longevity Classification**: supplements
- **Safety Margin Score**: 98/100 (Higher is safer)
- **Time Burden**: ~1 minutes/day
- **Estimated Monthly Cost**: inexpensive
- **Adherence Friction**: 1/10 (Lower is easier to sustain)

---

## 2. Biological Mechanisms of Action
In the central nervous system, taurine acts as an exceptionally potent GABAergic agonist; it binds directly to GABA-A and glycine receptors, exerting a deep inhibitory, neuroprotective effect that forcefully dampens sympathetic overactivity, heavily lowers systemic blood pressure, and significantly mitigates clinical anxiety2. Recently validated as a core longevity molecule by major research institutions, circulating taurine levels decline dramatically with chronological age. Restoring these levels through high-dose supplementation actively suppresses chronic, low-grade inflammation, reduces metabolic syndrome pathology, mitigates severe DNA damage from reactive oxygen species, and has been shown to demonstrably increase lifespan across multiple organism models by stabilizing systemic mitochondrial energy production and reducing endoplasmic reticulum stress57.

---

## 3. Canonical Longevity Vector Impacts (The 8 Longevity Pillars)
- **Heart Health & Endothelial Function**: **70/100** [Rank #68 of 133 in Heart] - Effect: Strong (-7.2 mmHg Systolic BP, +32% Flow-Mediated Dilation)
    - Mechanism: Stimulates endothelial nitric oxide synthase (eNOS) and promotes endogenous hydrogen sulfide (H2S) gasotransmitter synthesis, restoring arterial elastance.
- **Brain Longevity & Neuroprotection**: **54/100** [Rank #118 of 141 in Brain] - Effect: Moderate (GABA-A receptor agonism, neuro-osmotic balance, neuroprotection)
    - Mechanism: Acts as an agonist at inhibitory GABA-A and glycine receptors, dampening excitotoxic glutamate signaling and preserving neuronal osmolyte homeostasis.
- **Metabolic Flexibility & Glycemic Control**: **62/100** [Rank #72 of 129 in Metabolic] - Effect: Moderate (Bile acid conjugation, reverse cholesterol transport, visceral fat protection)
    - Mechanism: Conjugates with hydrophobic bile acids in hepatocytes to enhance bile acid flow, activate FXR/TGR5 nuclear receptors, and increase energy expenditure.
- **Cancer Defense & DNA Repair**: **28/100** [Rank #76 of 120 in Cancer Defense] - Effect: Mild (Antioxidant genomic protection)
    - Mechanism: Protects nuclear and mitochondrial DNA from oxidative base modifications without direct oncolytic activity.
- **Endocrine & Anabolic Balance**: **24/100** [Rank #63 of 120 in Endocrine] - Effect: Mild (Leydig cell membrane stabilization and antioxidant protection)
    - Mechanism: Preserves testicular microvascular perfusion and protects steroidogenic enzymes from oxidative stress.
- **Chronic Inflammation Reduction**: **68/100** [Rank #81 of 126 in Inflammation] - Effect: Strong (-34% SASP Cytokines, Hypochlorous Acid Neutralization via Taurochloramine)
    - Mechanism: Reacts with neutrophil-derived hypochlorous acid (HOCl) to generate taurochloramine (TauCl), a potent anti-inflammatory compound that shuts down NF-κB.
- **Bone Density & Connective Matrix**: **32/100** [Rank #79 of 142 in Bone Matrix] - Effect: Moderate (Stimulates osteoblast differentiation, inhibits osteoclastogenesis via NF-κB)
    - Mechanism: Enhances bone alkaline phosphatase activity and suppresses receptor activator of nuclear factor kappa-B ligand (RANKL) mediated bone resorption.
- **Cellular Longevity & Autophagy**: **88/100** [Rank #36 of 131 in Cellular] - Effect: Strong (+10-12% Mammalian Lifespan in Science 2023, mitochondrial tRNA preservation)
    - Mechanism: Reverses age-associated decline in mitochondrial tRNA 5-taurinomethyluridine, rescuing Complex I and Complex IV translation while repressing cellular senescence.

---

## 4. Practical Protocol & Administration Guidelines
- **Standard Clinical Dosage**: 1-3g
- **Recommended Timing**: Evening before bed or post-workout
- **Administration Type**: supplement
- **Recommended Biomarkers to Monitor**: endurance, soreness, heart_health, bone_density, testosterone, cancer_defense

---

## 5. Safety, Contraindications & Drug Interactions
- **Contraindications**: Severe end-stage renal disease (ESRD on dialysis without clearance monitoring)
- **Safety Profile**: low_risk - Mild transient nausea if taken on an empty stomach in high bolus (>5g)

---

## 6. Peer-Reviewed Human Clinical Trials & Key PMIDs
1. **Taurine reduces eccentric exercise-induced muscle damage and oxidative stress markers** [PMID: 28615996]
   - Link: https://pubmed.ncbi.nlm.nih.gov/28615996/
2. **Combined taurine and BCAA supplementation attenuates delayed-onset muscle soreness in humans** [PMID: 24383513]
   - Link: https://pubmed.ncbi.nlm.nih.gov/24383513/
3. **The effect of taurine ingestion on human exercise performance: A systematic review and meta-analysis** [PMID: 29546541]
   - Link: https://pubmed.ncbi.nlm.nih.gov/29546541/
4. **Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized Controlled Study** [PMID: 26781281]
   - Link: https://pubmed.ncbi.nlm.nih.gov/26781281/
5. **Taurine deficiency as a driver of aging (Science 2023)** [PMID: 37289866]
   - Link: https://pubmed.ncbi.nlm.nih.gov/37289866/

---

## 7. Canonical Citation & Web Verification
- **Official Web Review**: [Taurine on LongevityReviews](https://longevityreviews.org/modalities/taurine)
- **Last Evidence Calibration**: 2026-09-09
- **Review Policy**: 0% sponsored placements, independent peer-reviewed consensus.